https://scholars.lib.ntu.edu.tw/handle/123456789/525046
標題: | Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era | 作者: | Chieh-Lung Cheng Huang, Sheng-Chuan Chen, Jia-Hong Wei, Chao-Hung Fang, Wei-Quan TUNG-HUNG SU CHANG-TSU YUAN JIA-HAU LIU MING-KAI CHUANG HWEI-FANG TIEN |
關鍵字: | Diffuse large B-cell lymphoma; Hepatitis B surface antigen; Hepatitis B virus infection; Prognosis; Risk stratification | 公開日期: | 九月-2020 | 出版社: | WILEY | 卷: | 25 | 期: | 9 | 起(迄)頁: | 793 | 來源出版物: | The oncologist | 摘要: | Patients with diffuse large B-cell lymphoma (DLBCL) with concurrent hepatitis B surface antigen (HBsAg)-positive hepatitis B virus (HBV) infection have distinct clinical features. Nevertheless, the prognostic value of HBsAg in DLBCL in the rituximab era remains unclear. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/525046 | ISSN: | 1083-7159 1549-490X |
DOI: | 10.1634/theoncologist.2019-0756 | SDG/關鍵字: | albumin; cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine; hepatitis B core antibody; hepatitis B surface antigen; hepatitis B(e) antigen; hepatitis C virus antibody; lactate dehydrogenase; rituximab; unclassified drug; antineoplastic agent; cyclophosphamide; doxorubicin; hepatitis B surface antigen; prednisone; rituximab; vincristine; adult; aged; antigen detection; Article; autologous stem cell transplantation; cancer prognosis; clinical feature; clinical outcome; cohort analysis; diffuse large B cell lymphoma; female; follow up; hepatitis B; human; liver failure; lymphocyte count; major clinical study; male; monocyte count; multiple cycle treatment; outcome assessment; overall survival; prevalence; priority journal; prognostic assessment; progression free survival; prophylaxis; retrospective study; treatment response; validation process; virus load; virus reactivation; prognosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hepatitis B Surface Antigens; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。